BioCatalystWatch
DRMAWorkspace / DRMA / OverviewCompany library
Dermata Therapeutics, Inc. logo

Dermata Therapeutics, Inc.

Dermata Therapeutics, Inc. (DRMA)

Website

Featured programme · DMT410

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Other pipelines

XYNGARI (DMT310)

PreINDP1P2P3FilingApproved
DMT410

PreINDP1P2P3FilingApproved

History / paused

XYNGARI (DMT310)

PreINDP1P2P3FilingApproved
XYNGARI (DMT310)

PreINDP1P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

DRMA PR & News

PR & News

DRMA SEC archive